New hope for kids with relapsed cancer: drug combo shows promise in early trial
NCT ID NCT02512926
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 27 times
Summary
This early-phase study tested a three-drug combination (carfilzomib, cyclophosphamide, and etoposide) in 4 children whose solid tumors or leukemias had returned or were not responding to standard treatments. The main goal was to find the safest dose and identify side effects. The study was completed but did not move to a larger trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8, Canada
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
Penn State Hershey Children's Hospital
Hershey, Pennsylvania, 17033-0850, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Stanford University School of Medicine and Stanford Cancer Institute
Palo Alto, California, 94304, United States
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.